MX2019014313A - Combinacion que comprende acido decanoico para el tratamiento de la epilepsia. - Google Patents
Combinacion que comprende acido decanoico para el tratamiento de la epilepsia.Info
- Publication number
- MX2019014313A MX2019014313A MX2019014313A MX2019014313A MX2019014313A MX 2019014313 A MX2019014313 A MX 2019014313A MX 2019014313 A MX2019014313 A MX 2019014313A MX 2019014313 A MX2019014313 A MX 2019014313A MX 2019014313 A MX2019014313 A MX 2019014313A
- Authority
- MX
- Mexico
- Prior art keywords
- decanoic acid
- combination
- epilepsy
- treatment
- perampanel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Ácido decanoico para usar en el tratamiento de la epilepsia caracterizado porque el ácido decanoico se usa en combinación con perampanel, o una sal farmacéuticamente aceptable de este, o en donde el ácido decanoico se usa en combinación con un inhibidor del receptor AMPA que se une al mismo sitio receptor AMPA que el perampanel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17178751 | 2017-06-29 | ||
PCT/EP2018/067355 WO2019002435A1 (en) | 2017-06-29 | 2018-06-28 | COMBINATION COMPRISING DECANOIC ACID FOR THE TREATMENT OF EPILEPSY |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019014313A true MX2019014313A (es) | 2022-08-04 |
Family
ID=59258096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019014313A MX2019014313A (es) | 2017-06-29 | 2018-06-28 | Combinacion que comprende acido decanoico para el tratamiento de la epilepsia. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20200215013A1 (es) |
EP (1) | EP3644985A1 (es) |
JP (1) | JP2020525412A (es) |
CN (1) | CN110799185A (es) |
AU (2) | AU2018293718B2 (es) |
BR (1) | BR112019026297A2 (es) |
CA (1) | CA3064329A1 (es) |
MX (1) | MX2019014313A (es) |
WO (1) | WO2019002435A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3958973A4 (en) * | 2019-04-26 | 2023-06-07 | Cytosolve, Inc. | COMPOSITIONS TO IMPROVE BRAIN HEALTH AND MEMORY |
WO2021240540A1 (en) | 2020-05-26 | 2021-12-02 | Celagenex Research (India) Pvt. Ltd. | Novel synergistic nutritional compositions for treating seizures and chronic inflammatory diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8343541B2 (en) * | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
GB201210699D0 (en) * | 2012-06-15 | 2012-08-01 | Vitaflo Ltd | Nutritional food |
CN104649962A (zh) * | 2013-11-25 | 2015-05-27 | 天津市汉康医药生物技术有限公司 | 吡仑帕奈倍半水合物化合物 |
-
2018
- 2018-06-28 JP JP2019567737A patent/JP2020525412A/ja active Pending
- 2018-06-28 CN CN201880040956.0A patent/CN110799185A/zh active Pending
- 2018-06-28 WO PCT/EP2018/067355 patent/WO2019002435A1/en unknown
- 2018-06-28 CA CA3064329A patent/CA3064329A1/en active Pending
- 2018-06-28 AU AU2018293718A patent/AU2018293718B2/en active Active
- 2018-06-28 MX MX2019014313A patent/MX2019014313A/es unknown
- 2018-06-28 US US16/624,381 patent/US20200215013A1/en active Pending
- 2018-06-28 EP EP18738230.4A patent/EP3644985A1/en active Pending
- 2018-06-28 BR BR112019026297-0A patent/BR112019026297A2/pt unknown
-
2024
- 2024-04-11 AU AU2024202343A patent/AU2024202343A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112019026297A2 (pt) | 2020-06-30 |
RU2020102276A3 (es) | 2022-01-21 |
US20200215013A1 (en) | 2020-07-09 |
JP2020525412A (ja) | 2020-08-27 |
CN110799185A (zh) | 2020-02-14 |
WO2019002435A1 (en) | 2019-01-03 |
RU2020102276A (ru) | 2021-08-02 |
EP3644985A1 (en) | 2020-05-06 |
CA3064329A1 (en) | 2019-01-03 |
AU2018293718A1 (en) | 2019-11-28 |
AU2018293718B2 (en) | 2024-01-18 |
AU2024202343A1 (en) | 2024-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
PH12018500040A1 (en) | Indazole and azaindazole compounds as irak-4 inhibitors | |
PH12019501321B1 (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders | |
PH12018502102A1 (en) | Pyrrolotriazine compounds as tam inhibitors | |
PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
PH12017502107A1 (en) | Triazole agonists of the apj receptor | |
EA201790766A1 (ru) | Новые соединения метилпиперидина, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
MX2018006674A (es) | Tratamiento de cancer usando 2-desoxi-2-fluoro-l-fucosa en combinacion con un inhibidor del punto de control. | |
EP4282479A3 (en) | Use of pridopidine to treat depression or anxiety | |
MX2017014192A (es) | Composiciones y metodos de tratamiento de una enfermedad neurodegenerativa. | |
MY192055A (en) | Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation | |
SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
MX2015016100A (es) | Inhibidores de criopirina para prevenir y tratar la inflamacion. | |
PH12016502353A1 (en) | Pharmaceutical composition | |
TW201713341A (en) | Compositions and methods of treating a neurodegenerative disease | |
PH12016502352A1 (en) | Pharmaceutical composition | |
MX2019013808A (es) | Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer. | |
MX2015012741A (es) | Palbociclib deuterado. | |
MX2016016404A (es) | Metodos para el tratamiento del prurito. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
MX2019014313A (es) | Combinacion que comprende acido decanoico para el tratamiento de la epilepsia. | |
MX2018001684A (es) | Metodo de curacion de heridas. | |
MY198753A (en) | Treatment of androgen deprivation therapy associated symptoms | |
MY195960A (en) | Benzoic Acid Salt for use in Preventing or Treating Anti-N-Methyl-D-Aspartate Receptor Encephalitis | |
TN2017000248A1 (en) | Cgrp antagonist peptides |